{
     "PMID": "7475932",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19951218",
     "LR": "20131121",
     "IS": "0024-3205 (Print) 0024-3205 (Linking)",
     "VI": "57",
     "IP": "20",
     "DP": "1995",
     "TI": "Pressor response induced by the hippocampal administration of neostigmine is suppressed by M1 muscarinic antagonist.",
     "PG": "1853-9",
     "AB": "We investigated the roles played by three muscarinic receptors (M1, M2, and M3) in the pressor response with bradycardia that followed the injection of neostigmine (5 x 10(-8) mol) into the hippocampus of anesthetized rats. These changes were blocked by the co-administration of methylatropine (5 x 10(-8) mol). The intrahippocampal injection of pirenzepine (M1 antagonist) (5 x 10(-9) - 5 x 10(-7) mol) suppressed the neostigmine-induced pressor response dose-dependently. However injection of gallamine (M2 antagonist) (5 x 10(-8) - 5 x 10(-7) mol) and of 4-DAMP (M1 and M3 antagonist) (5 x 10(-8) - 5 x 10(-7) mol) did not suppress this hypertensive response. These findings suggest that the neostigmine-induced pressor response with bradycardia is mediated through the M1 muscarinic receptor subtype.",
     "FAU": [
          "Hori, H",
          "Haruta, K",
          "Nanki, M",
          "Sakamoto, N",
          "Uemura, K",
          "Matsubara, T",
          "Itoh, K",
          "Iguchi, A"
     ],
     "AU": [
          "Hori H",
          "Haruta K",
          "Nanki M",
          "Sakamoto N",
          "Uemura K",
          "Matsubara T",
          "Itoh K",
          "Iguchi A"
     ],
     "AD": "Department of Internal Medicine, Chubu Rousai General Hospital, Labor Welfare Corporation, Nagoya, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Life Sci",
     "JT": "Life sciences",
     "JID": "0375521",
     "RN": [
          "0 (Atropine Derivatives)",
          "0 (Muscarinic Antagonists)",
          "0 (Parasympathomimetics)",
          "0 (Piperidines)",
          "0 (Receptors, Muscarinic)",
          "3982TWQ96G (Neostigmine)",
          "3G0285N20N (Pirenzepine)",
          "80719I460H (methylatropine)",
          "81405-11-0 (4-diphenylacetoxy-1,1-dimethylpiperidinium)",
          "Q3254X40X2 (Gallamine Triethiodide)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Atropine Derivatives/pharmacology",
          "Blood Pressure/*drug effects/physiology",
          "Drug Interactions",
          "Gallamine Triethiodide/pharmacology",
          "Heart Rate/drug effects",
          "Hippocampus/*drug effects/physiology",
          "Male",
          "Muscarinic Antagonists/*pharmacology",
          "Neostigmine/*antagonists & inhibitors/pharmacology",
          "Parasympathomimetics/*antagonists & inhibitors/pharmacology",
          "Piperidines/pharmacology",
          "Pirenzepine/pharmacology",
          "Pressoreceptors/drug effects/physiology",
          "Rats",
          "Rats, Wistar",
          "Receptors, Muscarinic/classification/physiology"
     ],
     "EDAT": "1995/01/01 00:00",
     "MHDA": "1995/01/01 00:01",
     "CRDT": [
          "1995/01/01 00:00"
     ],
     "PHST": [
          "1995/01/01 00:00 [pubmed]",
          "1995/01/01 00:01 [medline]",
          "1995/01/01 00:00 [entrez]"
     ],
     "AID": [
          "002432059502165F [pii]"
     ],
     "PST": "ppublish",
     "SO": "Life Sci. 1995;57(20):1853-9.",
     "term": "hippocampus"
}